Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.

Molecular pharmaceutics·2026

Same author

Formulation Development of Topical Inserts Containing Doxycycline and Doxycycline Combined with Tenofovir Alafenamide and Elvitegravir for the Prevention of Sexually Transmitted Infections.

AAPS PharmSciTech·2026

Same author

Artificial intelligence and machine learning in smart vaginal formulation development.

Advanced drug delivery reviews·2026

Same author

First-in-line 3D-printed intravaginal ring for nonhormonal contraception.

Drug delivery and translational research·2026

Same author

Partial Post-exposure Protection by Topical Inserts Containing Tenofovir Alafenamide Fumarate/Elvitegravir in a Macaque Model of Rectal Simian HIV (SHIV) Infection.

The Journal of infectious diseases·2025

Same author

First-in-line 3D-printed intravaginal ring for nonhormonal contraception.

Research square·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Biomarker discovery: validation and decision-making in product development.

R Sam Niedbala¹, Christine Mauck, Polly Harrison

¹Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania, USA.

Sexually Transmitted Diseases

|February 17, 2009

Summary

This conference focused on validating disease markers for developing new microbicides. Researchers shared methods for biomarker discovery and assessment in cancer and infectious diseases to advance therapeutic development.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Jun 25, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

Biomedical research
Drug development
Biomarker discovery

Background:

Conference convened microbicide researchers with drug prophylaxis and therapeutics development experts.
Session 1 aimed to share methods for validating disease markers and their performance logic.
Discussions covered biomarker identification, use, and assessment across development stages.

Purpose of the Study:

To share methods for validating disease markers.
To elucidate the logic behind substantiating marker performance.
To translate biomarker development experience into practical steps for microbicide development.

Main Methods:

Review of presentations from key researchers in biomarker development.
Discussion of experiences in de novo drug discovery and biomarker qualification.
Focus on biomarker identification, use, and assessment in clinical settings.

Main Results:

Shared methods for validating disease markers and substantiating their performance.
Identified pathways to translate biomarker development experience into microbicide development.
Covered complexity of biomarker assessment in cancer and infectious diseases.

Conclusions:

Biomarker validation and assessment are critical for microbicide development.
Cross-disciplinary collaboration is essential for advancing therapeutic discovery.
Translating biomarker research into practical applications requires shared methodologies.